3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 33746212 | The effects of new life-prolonging drugs for metastatic castration-resistant prostate cancer (mCRPC) patients in a real-world population. | 2021 Sep | 1 |
| 2 | 34084103 | Gemcitabine Plus Platinum versus Docetaxel Plus Platinum as First-Line Therapy for Metastatic Nasopharyngeal Carcinoma: A Randomized Clinical Study. | 2021 May-Aug | 1 |
| 3 | 34976813 | Efficacy and Safety of Docetaxel and Sodium Cantharidinate Combination vs. Either Agent Alone as Second-Line Treatment for Advanced/Metastatic NSCLC With Wild-Type or Unknown EGFR Status: An Open-Label, Randomized Controlled, Prospective, Multi-Center Phase III Trial (Cando-L1). | 2021 | 1 |